[go: up one dir, main page]

GB9414193D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9414193D0
GB9414193D0 GB9414193A GB9414193A GB9414193D0 GB 9414193 D0 GB9414193 D0 GB 9414193D0 GB 9414193 A GB9414193 A GB 9414193A GB 9414193 A GB9414193 A GB 9414193A GB 9414193 D0 GB9414193 D0 GB 9414193D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9414193A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB9414193A priority Critical patent/GB9414193D0/en
Publication of GB9414193D0 publication Critical patent/GB9414193D0/en
Priority to ZA955784A priority patent/ZA955784B/en
Priority to IL11457895A priority patent/IL114578A0/en
Priority to AU36982/95A priority patent/AU3698295A/en
Priority to PCT/EP1995/002837 priority patent/WO1996002553A2/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9414193A 1994-07-14 1994-07-14 Compounds Pending GB9414193D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB9414193A GB9414193D0 (en) 1994-07-14 1994-07-14 Compounds
ZA955784A ZA955784B (en) 1994-07-14 1995-07-12 Amino purine-beta-D-ribofuranuronamide derivatives
IL11457895A IL114578A0 (en) 1994-07-14 1995-07-13 Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
AU36982/95A AU3698295A (en) 1994-07-14 1995-07-14 Amino purine-beta -d-ribofuranuronamide derivatives
PCT/EP1995/002837 WO1996002553A2 (en) 1994-07-14 1995-07-14 AMINO PURINE-β-D-RIBOFURANURONAMIDE DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414193A GB9414193D0 (en) 1994-07-14 1994-07-14 Compounds

Publications (1)

Publication Number Publication Date
GB9414193D0 true GB9414193D0 (en) 1994-08-31

Family

ID=10758311

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9414193A Pending GB9414193D0 (en) 1994-07-14 1994-07-14 Compounds

Country Status (5)

Country Link
AU (1) AU3698295A (en)
GB (1) GB9414193D0 (en)
IL (1) IL114578A0 (en)
WO (1) WO1996002553A2 (en)
ZA (1) ZA955784B (en)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (en) 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
PE20000270A1 (en) 1998-02-14 2000-05-20 Glaxo Group Ltd DERIVATIVES OF 2- (PURIN-9-IL) -TETRAHIDROFURAN-3,4-DIOL
GB9813535D0 (en) 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
CN1313861A (en) 1998-06-23 2001-09-19 葛兰素集团有限公司 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives
GB9813540D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
CA2336967C (en) 1998-07-10 2010-06-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor antagonists
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7378400B2 (en) 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
GB9924361D0 (en) 1999-10-14 1999-12-15 Pfizer Ltd Purine derivatives
EP1252160B1 (en) 2000-01-14 2006-08-16 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Methanocarba cycloalkyl nucleoside analogues
US20010051612A1 (en) * 2000-02-23 2001-12-13 Gloria Cristalli 2-Thioether A2A receptor agonists
US6921753B2 (en) 2000-06-27 2005-07-26 Pfizer Inc Purine derivatives
NZ532062A (en) 2001-10-01 2006-09-29 Univ Virginia 2-propynyl adenosine analogues having A2 adenosine recepter agonist activity and compositions thereof to treat inflammatory responses
AR044519A1 (en) 2003-05-02 2005-09-14 Novartis Ag DERIVATIVES OF PIRIDIN-TIAZOL AMINA AND PIRIMIDIN-TIAZOL AMINA
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
PE20060272A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
CN103087133B (en) 2004-05-26 2016-09-14 伊诺泰克制药公司 Purine derivatives as adenosine A1 receptor agonists and their usage
WO2006028618A1 (en) 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
WO2006023272A1 (en) 2004-08-02 2006-03-02 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having a2a agonist activity
SG155182A1 (en) 2004-08-02 2009-09-30 Univ Virginia 2-propynyl adenosine analogs with modified 5æ-ribose groups having a2a agonist activity
BRPI0515506A (en) 2004-09-20 2008-07-29 Inotek Pharmaceuticals Corp purine derivatives and methods of use thereof
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
MY144906A (en) 2005-10-21 2011-11-30 Novartis Ag Human antibodies against il13 and therapeutic uses
NZ568392A (en) 2005-11-30 2011-07-29 Inotek Pharmaceuticals Corp Purine derivatives and methods of use thereof
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
RU2457209C2 (en) 2006-04-21 2012-07-27 Новартис Аг Purine derivatives applicable as adenosine receptor a2a agonists
MX2009003185A (en) 2006-09-29 2009-04-03 Novartis Ag Pyrazolopyrimidines as p13k lipid kinase inhibitors.
AU2007315234A1 (en) 2006-10-30 2008-05-08 Novartis Ag Heterocyclic compounds as antiinflammatory agents
WO2009006089A2 (en) * 2007-06-29 2009-01-08 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services A2 adenosine receptor agonists
CN101910153B (en) 2008-01-11 2014-01-22 诺华股份有限公司 Pyrimidines as Kinase Inhibitors
PT2391366E (en) 2009-01-29 2013-02-05 Novartis Ag Substituted benzimidazoles for the treatment of astrocytomas
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
BR112012003262A8 (en) 2009-08-12 2016-05-17 Novartis Ag Heterocyclic Hydrazone Compounds and Their Uses to Treat Cancer and Inflammation
PE20121148A1 (en) 2009-08-17 2012-09-07 Intellikine Llc HETEROCYCLIC COMPOUNDS AND USES OF THEM
BR112012008061A2 (en) 2009-08-20 2016-03-01 Novartis Ag heterocyclic oxime compounds
WO2011068978A1 (en) 2009-12-02 2011-06-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives and dendrimer conjugates thereof
EP2523669B1 (en) 2010-01-11 2016-12-07 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
JP2013523739A (en) 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション Method for reducing intraocular pressure in humans using N6-cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
UY33597A (en) 2010-09-09 2012-04-30 Irm Llc COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
EP2673277A1 (en) 2011-02-10 2013-12-18 Novartis AG [1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
JP5808826B2 (en) 2011-02-23 2015-11-10 インテリカイン， エルエルシー Heterocyclic compounds and uses thereof
BR112013021638A2 (en) 2011-02-25 2016-08-02 Irm Llc "trk inhibiting compounds, their use and compositions comprising them"
EP2755976B1 (en) 2011-09-15 2018-07-18 Novartis AG 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors
US20130209543A1 (en) 2011-11-23 2013-08-15 Intellikine Llc Enhanced treatment regimens using mtor inhibitors
NZ627778A (en) 2012-01-26 2017-01-27 Inotek Pharmaceuticals Corp Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
JP2015512425A (en) 2012-04-03 2015-04-27 ノバルティス アーゲー Combination products with tyrosine kinase inhibitors and their use
WO2014151147A1 (en) 2013-03-15 2014-09-25 Intellikine, Llc Combination of kinase inhibitors and uses thereof
BR112015021870A2 (en) 2013-03-15 2017-07-18 Inotek Pharmaceuticals Corp ophthalmic formulations
WO2015084804A1 (en) 2013-12-03 2015-06-11 Novartis Ag Combination of mdm2 inhibitor and braf inhibitor and their use
WO2016011658A1 (en) 2014-07-25 2016-01-28 Novartis Ag Combination therapy
AU2015294889B2 (en) 2014-07-31 2018-03-15 Novartis Ag Combination therapy
CN109879787A (en) * 2019-01-10 2019-06-14 安徽昊帆生物有限公司 Iodo acetylthiocholine, preparation method and its application
TW202140550A (en) 2020-01-29 2021-11-01 瑞士商諾華公司 Methods of treating an inflammatory or obstructive airway disease using anti-tslp antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738954A (en) * 1985-11-06 1988-04-19 Warner-Lambert Company Novel N6 -substituted-5'-oxidized adenosine analogs
WO1988003147A1 (en) * 1986-10-31 1988-05-05 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
PT86660B (en) * 1987-02-04 1992-02-28 Ciba Geigy Ag PROCESS FOR THE PREPARATION OF ADENOSIN-5'-CARBOXAMIDE DERIVATIVES

Also Published As

Publication number Publication date
AU3698295A (en) 1996-02-16
IL114578A0 (en) 1995-11-27
WO1996002553A3 (en) 1996-03-07
WO1996002553A2 (en) 1996-02-01
ZA955784B (en) 1996-08-15

Similar Documents

Publication Publication Date Title
GB9414193D0 (en) Compounds
GB9414208D0 (en) Compounds
GB9404706D0 (en) Compounds
GB9406043D0 (en) Compounds
GB9409921D0 (en) Compounds
GB9407435D0 (en) Compounds
GB9402197D0 (en) Compounds
GB9403199D0 (en) Compounds
GB9400413D0 (en) Compounds
GB9417938D0 (en) Compounds
GB9402041D0 (en) Compounds
GB9410035D0 (en) Compounds
GB9402603D0 (en) Compounds
GB2296241B (en) Compounds
GB9413498D0 (en) Compounds
GB9420093D0 (en) Compounds
GB9411103D0 (en) Compounds
GB9406181D0 (en) Compounds
GB9410205D0 (en) Compounds
GB9411482D0 (en) Compounds
GB9411997D0 (en) Compounds
GB9413233D0 (en) Compounds
GB9406394D0 (en) Compounds
GB9406398D0 (en) Compounds
GB9406182D0 (en) Compounds